Issue 30, 2024

An engineered POSS drug delivery system for copper(ii) anticancer metallodrugs in a selective application toward melanoma cells

Abstract

In this work, a polyhedral silsesquioxane (POSS) was used as an engineered drug delivery system for two oxindolimine–copper(II) anticancer complexes, [Cu(isaepy)]+ and [Cu(isapn)]+. The interest in hybrid POSS comes from the necessity of developing materials that can act as adjuvants to improve the cytotoxicity of non-soluble metallodrugs. Functionalization of POSS with a triazole ligand (POSS-atzac) permitted the anchorage of such copper complexes, producing hybrid materials with efficient cytotoxic effects. Structural and morphological characterizations of these copper-POSS systems were performed by using different techniques (IR, NMR, thermogravimetric analysis). A combination of continuous-wave (CW) and pulsed EPR (HYSCORE) spectroscopies conducted at the X-band have enabled the complete characterization of the coordination environment of the copper ion in the POSS-atzac matrix. Additionally, the cytotoxic effects of the loaded materials, [Cu(isapn)]@POSS-atzac and [Cu(isaepy)]@POSS-atzac, were assessed toward melanomas (SK-MEL), in comparison to non-tumorigenic cells (fibroblast P4). Evaluation of their nuclease activity or ability to facilitate cleavage of DNA indicated concentrations as low as 0.6 μg mL−1, while complete DNA fragmentation was observed at 25 μg mL−1. By using adequate scavengers, investigations on active intermediates responsible for their cytotoxicity were performed, both in the absence and in the presence of ascorbate as a reducing agent. Based on the observed selective cytotoxicity of these materials toward melanomas, investigations on the reactivity of these complexes and corresponding POSS-materials with melanin, a molecule that contributes to melanoma resistance to chemotherapy, were carried out. Results indicated the main role of the binuclear copper species, formed at the surface of the silica matrix, in the observed reactivity and selectivity of these copper-POSS systems.

Graphical abstract: An engineered POSS drug delivery system for copper(ii) anticancer metallodrugs in a selective application toward melanoma cells

Supplementary files

Article information

Article type
Paper
Submitted
23 Feb 2024
Accepted
20 Jun 2024
First published
26 Jun 2024

Dalton Trans., 2024,53, 12567-12581

An engineered POSS drug delivery system for copper(II) anticancer metallodrugs in a selective application toward melanoma cells

E. G. Vieira, R. E. F. de Paiva, R. B. Miguel, A. P. A. de Oliveira, F. Franco de Melo Bagatelli, C. C. Oliveira, F. Tuna and A. M. da Costa Ferreira, Dalton Trans., 2024, 53, 12567 DOI: 10.1039/D4DT00535J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements